360 related articles for article (PubMed ID: 25071337)
41. Implementing a fracture liaison service open model of care utilizing a cloud-based tool.
Greenspan SL; Singer A; Vujevich K; Marchand B; Thompson DA; Hsu YJ; Vaidya D; Stern LS; Zeldow D; Lee DB; Karp S; Recker R
Osteoporos Int; 2018 Apr; 29(4):953-960. PubMed ID: 29429033
[TBL] [Abstract][Full Text] [Related]
42. Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children.
Galindo-Zavala R; Bou-Torrent R; Magallares-López B; Mir-Perelló C; Palmou-Fontana N; Sevilla-Pérez B; Medrano-San Ildefonso M; González-Fernández MI; Román-Pascual A; Alcañiz-Rodríguez P; Nieto-Gonzalez JC; López-Corbeto M; Graña-Gil J
Pediatr Rheumatol Online J; 2020 Feb; 18(1):20. PubMed ID: 32093703
[TBL] [Abstract][Full Text] [Related]
43. Calcium and vitamin D for osteoporotic fracture prevention.
Carmona RJ; Adachi JD
Pol Arch Med Wewn; 2007 Oct; 117(10):441-2. PubMed ID: 18320782
[No Abstract] [Full Text] [Related]
44. [Osteoporosis: prophylaxis, diagnostics and therapy according to the guidelines].
Lange U; Müller-Ladner U; Pfeilschifter J
Internist (Berl); 2011 Jul; 52(7):843-52; quiz 853. PubMed ID: 21544508
[TBL] [Abstract][Full Text] [Related]
45. Osteoporosis in the Women's Health Initiative: Another Treatment Gap?
Sattari M; Cauley JA; Garvan C; Johnson KC; LaMonte MJ; Li W; Limacher M; Manini T; Sarto GE; Sullivan SD; Wactawski-Wende J; Beyth RJ
Am J Med; 2017 Aug; 130(8):937-948. PubMed ID: 28366425
[TBL] [Abstract][Full Text] [Related]
46. Dilemmas in the management of osteoporosis.
Drug Ther Bull; 2015 Feb; 53(2):18-21. PubMed ID: 25678351
[TBL] [Abstract][Full Text] [Related]
47. Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.
Hansen L; Petersen KD; Eriksen SA; Gerstoft F; Vestergaard P
Osteoporos Int; 2017 Jan; 28(1):321-328. PubMed ID: 27475930
[TBL] [Abstract][Full Text] [Related]
48. Vitamin K supplementation for the primary prevention of osteoporotic fractures: is it cost-effective and is future research warranted?
Gajic-Veljanoski O; Bayoumi AM; Tomlinson G; Khan K; Cheung AM
Osteoporos Int; 2012 Nov; 23(11):2681-92. PubMed ID: 22398856
[TBL] [Abstract][Full Text] [Related]
49. Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence.
Boonen S; Bischoff-Ferrari HA; Cooper C; Lips P; Ljunggren O; Meunier PJ; Reginster JY
Calcif Tissue Int; 2006 May; 78(5):257-70. PubMed ID: 16622587
[TBL] [Abstract][Full Text] [Related]
50. Chronic Pancreatitis and Bone Disease.
Barkin JA; Barkin JS
J Clin Densitom; 2020; 23(2):237-243. PubMed ID: 31558406
[TBL] [Abstract][Full Text] [Related]
51. Osteoporosis in chronic liver disease.
Yadav A; Carey EJ
Nutr Clin Pract; 2013 Feb; 28(1):52-64. PubMed ID: 23263929
[TBL] [Abstract][Full Text] [Related]
52. [Osteoporosis].
Uebelhart B; Rizzoli R
Rev Med Suisse; 2013 Jan; 9(369):125-31. PubMed ID: 23409650
[TBL] [Abstract][Full Text] [Related]
53. Osteoporosis diagnosis and medical treatment.
Warriner AH; Saag KG
Orthop Clin North Am; 2013 Apr; 44(2):125-35. PubMed ID: 23544819
[TBL] [Abstract][Full Text] [Related]
54. Successful knowledge translation intervention in long-term care: final results from the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial.
Kennedy CC; Ioannidis G; Thabane L; Adachi JD; Marr S; Giangregorio LM; Morin SN; Crilly RG; Josse RG; Lohfeld L; Pickard LE; van der Horst ML; Campbell G; Stroud J; Dolovich L; Sawka AM; Jain R; Nash L; Papaioannou A
Trials; 2015 May; 16():214. PubMed ID: 25962885
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort.
Sanfélix-Genovés J; Sanfélix-Gimeno G; Peiró S; Hurtado I; Fluixà C; Fuertes A; Campos JC; Giner V; Baixauli C
Osteoporos Int; 2013 Mar; 24(3):1045-55. PubMed ID: 22618269
[TBL] [Abstract][Full Text] [Related]
56. Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.
Bover J; Bailone L; López-Báez V; Benito S; Ciceri P; Galassi A; Cozzolino M
J Nephrol; 2017 Oct; 30(5):677-687. PubMed ID: 28432640
[TBL] [Abstract][Full Text] [Related]
57. Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis.
Nurmi-Lüthje I; Lüthje P; Kaukonen JP; Kataja M; Kuurne S; Naboulsi H; Karjalainen K
Drugs Aging; 2009; 26(5):409-21. PubMed ID: 19552493
[TBL] [Abstract][Full Text] [Related]
58. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
59. Who should receive calcium and vitamin D supplementation?
Verbrugge FH; Gielen E; Milisen K; Boonen S
Age Ageing; 2012 Sep; 41(5):576-80. PubMed ID: 22877606
[TBL] [Abstract][Full Text] [Related]
60. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
